2024-01-012024-12-312024-12-31false11123339GUITAR ANATOMY LIMITED2025-09-23falseiso4217:GBPxbrli:pure111233392023-12-31111233392024-12-31111233392024-01-012024-12-31111233392022-12-31111233392023-12-31111233392023-01-012023-12-3111123339bus:SmallEntities2024-01-012024-12-3111123339bus:AuditExempt-NoAccountantsReport2024-01-012024-12-3111123339bus:FullAccounts2024-01-012024-12-3111123339bus:PrivateLimitedCompanyLtd2024-01-012024-12-3111123339core:WithinOneYear2024-12-3111123339core:AfterOneYear2024-12-3111123339core:WithinOneYear2023-12-3111123339core:AfterOneYear2023-12-3111123339core:ShareCapital2024-12-3111123339core:SharePremium2024-12-3111123339core:RevaluationReserve2024-12-3111123339core:OtherReservesSubtotal2024-12-3111123339core:RetainedEarningsAccumulatedLosses2024-12-3111123339core:ShareCapital2023-12-3111123339core:SharePremium2023-12-3111123339core:RevaluationReserve2023-12-3111123339core:OtherReservesSubtotal2023-12-3111123339core:RetainedEarningsAccumulatedLosses2023-12-3111123339core:LandBuildings2024-12-3111123339core:PlantMachinery2024-12-3111123339core:Vehicles2024-12-3111123339core:FurnitureFittings2024-12-3111123339core:OfficeEquipment2024-12-3111123339core:NetGoodwill2024-12-3111123339core:IntangibleAssetsOtherThanGoodwill2024-12-3111123339core:ListedExchangeTraded2024-12-3111123339core:UnlistedNon-exchangeTraded2024-12-3111123339core:LandBuildings2023-12-3111123339core:PlantMachinery2023-12-3111123339core:Vehicles2023-12-3111123339core:FurnitureFittings2023-12-3111123339core:OfficeEquipment2023-12-3111123339core:NetGoodwill2023-12-3111123339core:IntangibleAssetsOtherThanGoodwill2023-12-3111123339core:ListedExchangeTraded2023-12-3111123339core:UnlistedNon-exchangeTraded2023-12-3111123339core:LandBuildings2024-01-012024-12-3111123339core:PlantMachinery2024-01-012024-12-3111123339core:Vehicles2024-01-012024-12-3111123339core:FurnitureFittings2024-01-012024-12-3111123339core:OfficeEquipment2024-01-012024-12-3111123339core:NetGoodwill2024-01-012024-12-3111123339core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3111123339core:ListedExchangeTraded2024-01-012024-12-3111123339core:UnlistedNon-exchangeTraded2024-01-012024-12-3111123339core:MoreThanFiveYears2024-01-012024-12-3111123339core:Non-currentFinancialInstruments2024-12-3111123339core:Non-currentFinancialInstruments2023-12-3111123339dpl:CostSales2024-01-012024-12-3111123339dpl:DistributionCosts2024-01-012024-12-3111123339core:LandBuildings2024-01-012024-12-3111123339core:PlantMachinery2024-01-012024-12-3111123339core:Vehicles2024-01-012024-12-3111123339core:FurnitureFittings2024-01-012024-12-3111123339core:OfficeEquipment2024-01-012024-12-3111123339dpl:AdministrativeExpenses2024-01-012024-12-3111123339core:NetGoodwill2024-01-012024-12-3111123339core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3111123339dpl:GroupUndertakings2024-01-012024-12-3111123339dpl:ParticipatingInterests2024-01-012024-12-3111123339dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012024-12-3111123339core:ListedExchangeTraded2024-01-012024-12-3111123339dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012024-12-3111123339core:UnlistedNon-exchangeTraded2024-01-012024-12-3111123339dpl:CostSales2023-01-012023-12-3111123339dpl:DistributionCosts2023-01-012023-12-3111123339core:LandBuildings2023-01-012023-12-3111123339core:PlantMachinery2023-01-012023-12-3111123339core:Vehicles2023-01-012023-12-3111123339core:FurnitureFittings2023-01-012023-12-3111123339core:OfficeEquipment2023-01-012023-12-3111123339dpl:AdministrativeExpenses2023-01-012023-12-3111123339core:NetGoodwill2023-01-012023-12-3111123339core:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3111123339dpl:GroupUndertakings2023-01-012023-12-3111123339dpl:ParticipatingInterests2023-01-012023-12-3111123339dpl:GroupUndertakingscore:ListedExchangeTraded2023-01-012023-12-3111123339core:ListedExchangeTraded2023-01-012023-12-3111123339dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-01-012023-12-3111123339core:UnlistedNon-exchangeTraded2023-01-012023-12-3111123339core:NetGoodwill2024-12-3111123339core:IntangibleAssetsOtherThanGoodwill2024-12-3111123339core:LandBuildings2024-12-3111123339core:PlantMachinery2024-12-3111123339core:Vehicles2024-12-3111123339core:FurnitureFittings2024-12-3111123339core:OfficeEquipment2024-12-3111123339core:AfterOneYear2024-12-3111123339core:WithinOneYear2024-12-3111123339core:ListedExchangeTraded2024-12-3111123339core:UnlistedNon-exchangeTraded2024-12-3111123339core:ShareCapital2024-12-3111123339core:SharePremium2024-12-3111123339core:RevaluationReserve2024-12-3111123339core:OtherReservesSubtotal2024-12-3111123339core:RetainedEarningsAccumulatedLosses2024-12-3111123339core:NetGoodwill2023-12-3111123339core:IntangibleAssetsOtherThanGoodwill2023-12-3111123339core:LandBuildings2023-12-3111123339core:PlantMachinery2023-12-3111123339core:Vehicles2023-12-3111123339core:FurnitureFittings2023-12-3111123339core:OfficeEquipment2023-12-3111123339core:AfterOneYear2023-12-3111123339core:WithinOneYear2023-12-3111123339core:ListedExchangeTraded2023-12-3111123339core:UnlistedNon-exchangeTraded2023-12-3111123339core:ShareCapital2023-12-3111123339core:SharePremium2023-12-3111123339core:RevaluationReserve2023-12-3111123339core:OtherReservesSubtotal2023-12-3111123339core:RetainedEarningsAccumulatedLosses2023-12-3111123339core:NetGoodwill2022-12-3111123339core:IntangibleAssetsOtherThanGoodwill2022-12-3111123339core:LandBuildings2022-12-3111123339core:PlantMachinery2022-12-3111123339core:Vehicles2022-12-3111123339core:FurnitureFittings2022-12-3111123339core:OfficeEquipment2022-12-3111123339core:AfterOneYear2022-12-3111123339core:WithinOneYear2022-12-3111123339core:ListedExchangeTraded2022-12-3111123339core:UnlistedNon-exchangeTraded2022-12-3111123339core:ShareCapital2022-12-3111123339core:SharePremium2022-12-3111123339core:RevaluationReserve2022-12-3111123339core:OtherReservesSubtotal2022-12-3111123339core:RetainedEarningsAccumulatedLosses2022-12-3111123339core:AfterOneYear2024-01-012024-12-3111123339core:WithinOneYear2024-01-012024-12-3111123339core:Non-currentFinancialInstrumentscore:CostValuation2024-01-012024-12-3111123339core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-012024-12-3111123339core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-012024-12-3111123339core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-012024-12-3111123339core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-012024-12-3111123339core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-012024-12-3111123339core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3111123339core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3111123339core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3111123339core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3111123339core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3111123339core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3111123339core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3111123339core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3111123339core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3111123339core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3111123339core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3111123339core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3111123339core:Non-currentFinancialInstrumentscore:CostValuation2023-12-3111123339core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-3111123339core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-3111123339core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-3111123339core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-3111123339core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-3111123339core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-3111123339core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-3111123339core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-3111123339bus:Director12024-01-012024-12-31

GUITAR ANATOMY LIMITED

Registered Number
11123339
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2024

GUITAR ANATOMY LIMITED
Company Information
for the year from 1 January 2024 to 31 December 2024

Director

NORTON, Joseph

Registered Address

2 Henson House Planet Place
Stephenson Industrial Estate
Newcastle Upon Tyne
NE12 6RZ

Registered Number

11123339 (England and Wales)
GUITAR ANATOMY LIMITED
Balance Sheet as at
31 December 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets335,00539,478
Investments420,000-
55,00539,478
Current assets
Stocks567,85065,765
Debtors66,8141
Cash at bank and on hand77,52843,225
152,192108,991
Creditors amounts falling due within one year7(53,854)(33,872)
Net current assets (liabilities)98,33875,119
Total assets less current liabilities153,343114,597
Creditors amounts falling due after one year8(15,984)(21,978)
Net assets137,35992,619
Capital and reserves
Called up share capital100100
Profit and loss account137,25992,519
Shareholders' funds137,35992,619
The financial statements were approved and authorised for issue by the Director on 23 September 2025, and are signed on its behalf by:
NORTON, Joseph
Director
Registered Company No. 11123339
GUITAR ANATOMY LIMITED
Notes to the Financial Statements
for the year ended 31 December 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)Straight line (years)
Vehicles5-
Office Equipment-4
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Stocks and work in progress
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
2.Average number of employees

20242023
Average number of employees during the year00
3.Tangible fixed assets

Vehicles

Office Equipment

Total

£££
Cost or valuation
At 01 January 2439,9705,11845,088
Additions-2,2652,265
At 31 December 2439,9707,38347,353
Depreciation and impairment
At 01 January 242,9972,6135,610
Charge for year5,3951,3436,738
At 31 December 248,3923,95612,348
Net book value
At 31 December 2431,5783,42735,005
At 31 December 2336,9732,50539,478
4.Fixed asset investments

Other investments1

Total

££
Cost or valuation
Additions20,00020,000
At 31 December 2420,00020,000
Net book value
At 31 December 2420,00020,000
At 31 December 23--

Notes

1Other investments other than loans
5.Stocks

2024

2023

££
Finished goods67,85065,765
Total67,85065,765
6.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables6,8141
Total6,8141
7.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables13,0474,393
Taxation and social security30,15319,288
Other creditors10,65410,191
Total53,85433,872
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
8.Creditors: amounts due after one year

2024

2023

££
Bank borrowings and overdrafts15,98421,978
Total15,98421,978